Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Self-measurement of Blood Glucose and Continuous Glucose Monitoring - Is There Only One Future?

Heinemann L, Stuhr A, Brown A, Freckmann G, Breton MD, Russell S, Heinemann L.

Eur Endocrinol. 2018 Sep;14(2):24-29. doi: 10.17925/EE.2018.14.2.24. Epub 2018 Sep 10. Review.

2.

Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems.

Garcia-Tirado J, Zuluaga-Bedoya C, Breton MD.

J Diabetes Sci Technol. 2018 Sep;12(5):937-952. doi: 10.1177/1932296818788873. Epub 2018 Aug 10.

PMID:
30095007
3.

Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting.

Renard E, Tubiana-Rufi N, Bonnemaison-Gilbert E, Coutant R, Dalla-Vale F, Farret A, Poidvin A, Bouhours-Nouet N, Abettan C, Storey-London C, Donzeau A, Place J, Breton MD.

Diabetes Obes Metab. 2019 Jan;21(1):183-187. doi: 10.1111/dom.13482. Epub 2018 Aug 21.

PMID:
30047223
4.

Diabetes Technological Revolution: Winners and Losers?

Barnard KD, Breton MD.

J Diabetes Sci Technol. 2018 Nov;12(6):1227-1230. doi: 10.1177/1932296818788872. Epub 2018 Jul 23.

PMID:
30035611
5.

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.

Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, Kollar L, Barnett C, Wakeman C, Oliveri M, Fabris C, Chernavvsky D, Kovatchev BP, Anderson SM.

Diabetes Technol Ther. 2018 Aug;20(8):531-540. doi: 10.1089/dia.2018.0079. Epub 2018 Jul 6.

PMID:
29979618
6.

Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England.

McQueen RB, Breton MD, Craig J, Holmes H, Whittington MD, Ott MA, Campbell JD.

J Diabetes Sci Technol. 2018 Sep;12(5):992-1001. doi: 10.1177/1932296818769098. Epub 2018 Apr 21.

PMID:
29681171
7.

Body Mass Index Effect on Differing Responses to Psychological Stress in Blood Glucose Dynamics in Patients With Type 1 Diabetes.

Ozaslan B, Patek SD, Grabman JH, Shepard JA, Dassau E, Breton MD, Kudva YC, Brown SA, Basu A, Pinsker JE, Doyle FJ 3rd, Gonder-Frederick L.

J Diabetes Sci Technol. 2018 May;12(3):657-664. doi: 10.1177/1932296818758103. Epub 2018 Feb 8.

8.

The Financial Impact of Inaccurate Blood Glucose Monitoring Systems.

Fortwaengler K, Campos-Náñez E, Parkin CG, Breton MD.

J Diabetes Sci Technol. 2018 Mar;12(2):318-324. doi: 10.1177/1932296817731423. Epub 2017 Sep 26.

9.

Recent Exposure to Hypoglycemia Increases Glucose Variability Following a Hyper/Hypoglycemic Metabolic Challenge in T1D.

Fabris C, Farhy LS, Anderson SM, Nass RM, Kovatchev BP, Breton MD.

J Diabetes Sci Technol. 2018 Mar;12(2):311-317. doi: 10.1177/1932296817729392. Epub 2017 Sep 25.

10.

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.

Breton MD, Cherñavvsky DR, Forlenza GP, DeBoer MD, Robic J, Wadwa RP, Messer LH, Kovatchev BP, Maahs DM.

Diabetes Care. 2017 Dec;40(12):1644-1650. doi: 10.2337/dc17-0883. Epub 2017 Aug 30.

11.

Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.

Gildersleeve R, Riggs SL, Cherñavvsky DR, Breton MD, DeBoer MD.

Diabetes Technol Ther. 2017 Nov;19(11):660-674. doi: 10.1089/dia.2017.0150. Epub 2017 Aug 30.

PMID:
28854339
12.

Analysis of the Accuracy and Performance of a Continuous Glucose Monitoring Sensor Prototype: An In-Silico Study Using the UVA/PADOVA Type 1 Diabetes Simulator.

Breton MD, Hinzmann R, Campos-Nañez E, Riddle S, Schoemaker M, Schmelzeisen-Redeker G.

J Diabetes Sci Technol. 2017 May;11(3):545-552. doi: 10.1177/1932296816680633. Epub 2016 Dec 13.

13.

Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.

Brown SA, Breton MD, Anderson SM, Kollar L, Keith-Hynes P, Levy CJ, Lam DW, Levister C, Baysal N, Kudva YC, Basu A, Dadlani V, Hinshaw L, McCrady-Spitzer S, Bruttomesso D, Visentin R, Galasso S, Del Favero S, Leal Y, Boscari F, Avogaro A, Cobelli C, Kovatchev BP.

J Clin Endocrinol Metab. 2017 Oct 1;102(10):3674-3682. doi: 10.1210/jc.2017-00556.

14.

Handling Exercise During Closed Loop Control.

Breton MD.

Diabetes Technol Ther. 2017 Jun;19(6):328-330. doi: 10.1089/dia.2017.0191. No abstract available.

15.

Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.

Campos-Náñez E, Fortwaengler K, Breton MD.

J Diabetes Sci Technol. 2017 Nov;11(6):1187-1195. doi: 10.1177/1932296817710474. Epub 2017 Jun 1.

16.

Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.

Campos-Náñez E, Breton MD.

J Diabetes Sci Technol. 2017 Nov;11(6):1196-1206. doi: 10.1177/1932296817710476. Epub 2017 May 31.

17.

Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.

DeBoer MD, Breton MD, Wakeman C, Schertz EM, Emory EG, Robic JL, Kollar LL, Kovatchev BP, Cherñavvsky DR.

Diabetes Technol Ther. 2017 May;19(5):293-298. doi: 10.1089/dia.2016.0424. Epub 2017 Apr 20.

PMID:
28426239
18.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Kovatchev B, Cheng P, Anderson SM, Pinsker JE, Boscari F, Buckingham BA, Doyle FJ 3rd, Hood KK, Brown SA, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Ly TT, Shanmugham S, Dassau E, Kollman C, Lum JW, Beck RW.

Diabetes Technol Ther. 2017 Jan;19(1):18-24. doi: 10.1089/dia.2016.0333. Epub 2016 Dec 16.

PMID:
27982707
19.

Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D.

DeBoer MD, Cherñavvsky DR, Topchyan K, Kovatchev BP, Francis GL, Breton MD.

Pediatr Diabetes. 2017 Nov;18(7):540-546. doi: 10.1111/pedi.12454. Epub 2016 Oct 13.

PMID:
27734563
20.

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp.

Ly TT, Buckingham BA, DeSalvo DJ, Shanmugham S, Satin-Smith M, DeBoer MD, Oliveri MC, Schertz E, Breton MD, Cherñavvsky DR.

Diabetes Care. 2016 Aug;39(8):e106-7. doi: 10.2337/dc16-0817. Epub 2016 Jun 6. No abstract available.

21.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

22.

Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 Diabetes.

Kovatchev BP, Breton MD.

J Diabetes Sci Technol. 2015 Nov 9;10(2):330-5. doi: 10.1177/1932296815608870.

23.

Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.

Ben Brahim N, Place J, Renard E, Breton MD.

J Diabetes Sci Technol. 2015 Oct 18;9(6):1185-91. doi: 10.1177/1932296815607864.

24.

Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.

Brown SA, Jiang B, McElwee-Malloy M, Wakeman C, Breton MD.

J Diabetes Sci Technol. 2015 Oct 14;9(6):1192-9. doi: 10.1177/1932296815608400.

25.

Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?

Fabris C, Patek SD, Breton MD.

J Diabetes Sci Technol. 2015 Aug 14;10(1):50-9. doi: 10.1177/1932296815599177.

26.

Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.

McQueen RB, Breton MD, Ott M, Koa H, Beamer B, Campbell JD.

J Diabetes Sci Technol. 2015 Aug 14;10(2):366-77. doi: 10.1177/1932296815599551.

27.

Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.

Finan DA, Dassau E, Breton MD, Patek SD, McCann TW Jr, Kovatchev BP, Doyle FJ 3rd, Levy BL, Venugopalan R.

J Diabetes Sci Technol. 2015 Jun 30;10(1):104-10. doi: 10.1177/1932296815593292.

28.

Pharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to Blood.

Lv D, Kulkarni SD, Chan A, Keith S, Pettis R, Kovatchev BP, Farhi LS, Breton MD.

J Diabetes Sci Technol. 2015 Jul;9(4):831-40. doi: 10.1177/1932296815573864. Epub 2015 Mar 9.

29.

Multinight "bedside" closed-loop control for patients with type 1 diabetes.

Brown SA, Kovatchev BP, Breton MD, Anderson SM, Keith-Hynes P, Patek SD, Jiang B, Ben Brahim N, Vereshchetin P, Bruttomesso D, Avogaro A, Del Favero S, Boscari F, Galasso S, Visentin R, Monaro M, Cobelli C.

Diabetes Technol Ther. 2015 Mar;17(3):203-9. doi: 10.1089/dia.2014.0259. Epub 2015 Jan 16.

30.

Computing the surveillance error grid analysis: procedure and examples.

Kovatchev BP, Wakeman CA, Breton MD, Kost GJ, Louie RF, Tran NK, Klonoff DC.

J Diabetes Sci Technol. 2014 Jul;8(4):673-84. doi: 10.1177/1932296814539590. Epub 2014 Jun 13.

31.

Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.

Kovatchev BP, Patek SD, Ortiz EA, Breton MD.

Diabetes Technol Ther. 2015 Mar;17(3):177-86. doi: 10.1089/dia.2014.0272. Epub 2014 Dec 1.

32.

Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.

Cherñavvsky DR, DeBoer MD, Keith-Hynes P, Mize B, McElwee M, Demartini S, Dunsmore SF, Wakeman C, Kovatchev BP, Breton MD.

Pediatr Diabetes. 2016 Feb;17(1):28-35. doi: 10.1111/pedi.12230. Epub 2014 Oct 27.

PMID:
25348683
33.

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd.

Diabetes Care. 2014 Jul;37(7):1789-96. doi: 10.2337/dc13-2076. Epub 2014 Jun 14.

34.

Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.

Ly TT, Breton MD, Keith-Hynes P, De Salvo D, Clinton P, Benassi K, Mize B, Chernavvsky D, Place J, Wilson DM, Kovatchev BP, Buckingham BA.

Diabetes Care. 2014 Aug;37(8):2310-6. doi: 10.2337/dc14-0147. Epub 2014 May 30.

35.

Effect of algorithm aggressiveness on the performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System.

Finan DA, McCann TW Jr, Rhein K, Dassau E, Breton MD, Patek SD, Anhalt H, Kovatchev BP, Doyle FJ 3rd, Anderson SM, Zisser H, Venugopalan R.

J Diabetes Sci Technol. 2014 Jul;8(4):685-90. doi: 10.1177/1932296814534589. Epub 2014 May 18.

36.

Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes.

Breton MD, Brown SA, Karvetski CH, Kollar L, Topchyan KA, Anderson SM, Kovatchev BP.

Diabetes Technol Ther. 2014 Aug;16(8):506-11. doi: 10.1089/dia.2013.0333. Epub 2014 Apr 4.

37.

Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine self-monitored blood glucose data.

Kovatchev BP, Flacke F, Sieber J, Breton MD.

Diabetes Technol Ther. 2014 May;16(5):303-9. doi: 10.1089/dia.2013.0224. Epub 2013 Dec 3.

38.

Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients.

Lv D, Breton MD, Farhy LS.

Diabetes Technol Ther. 2013 Nov;15(11):935-41. doi: 10.1089/dia.2013.0150. Epub 2013 Aug 26.

39.

Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ 3rd.

Diabetes Care. 2013 Jul;36(7):1851-8. doi: 10.2337/dc12-1965.

40.

Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.

Farhy LS, Chan A, Breton MD, Anderson SM, Kovatchev BP, McCall AL.

Front Physiol. 2012 Feb 28;3:40. doi: 10.3389/fphys.2012.00040. eCollection 2012.

41.

Historical data enhances safety supervision system performance in T1DM insulin therapy risk management.

Hughes-Karvetski C, Patek SD, Breton MD, Kovatchev BP.

Comput Methods Programs Biomed. 2013 Feb;109(2):220-5. doi: 10.1016/j.cmpb.2011.12.016. Epub 2012 Feb 17.

42.

Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus.

Chan A, Barrett EJ, Anderson SM, Kovatchev BP, Breton MD.

Diabetologia. 2012 Mar;55(3):729-36. doi: 10.1007/s00125-011-2402-3. Epub 2011 Dec 14.

43.
44.

Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitus.

Chan A, Heinemann L, Anderson SM, Breton MD, Kovatchev BP.

J Diabetes Sci Technol. 2010 Jul 1;4(4):873-81.

46.

Systematic method to assess microvascular recruitment using contrast-enhanced ultrasound. Application to insulin-induced capillary recruitment in subjects with T1DM.

Chan A, Kovatchev BP, Anderson SM, Breton MD.

Comput Methods Programs Biomed. 2011 May;102(2):219-26. doi: 10.1016/j.cmpb.2010.03.008. Epub 2010 Apr 30.

47.

Physical activity into the meal glucose-insulin model of type 1 diabetes: in silico studies.

Man CD, Breton MD, Cobelli C.

J Diabetes Sci Technol. 2009 Jan;3(1):56-67.

48.

Optimum subcutaneous glucose sampling and fourier analysis of continuous glucose monitors.

Breton MD, Shields DP, Kovatchev BP.

J Diabetes Sci Technol. 2008 May;2(3):495-500.

49.

Physical activity-the major unaccounted impediment to closed loop control.

Breton MD.

J Diabetes Sci Technol. 2008 Jan;2(1):169-74.

50.

Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels.

Chan A, Breton MD, Kovatchev BP.

J Diabetes Sci Technol. 2008 Sep;2(5):844-52.

Supplemental Content

Loading ...
Support Center